Feed LBRX
LB
LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
$47.78 +7.99% (+$3.53)
1M +56.19%
Market Cap $1.3B
P/E Ratio -
Div. Yield -
ROE 11.37%
Valuation
47 /100
Fair P/B 4.21x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 11.37%
ROA 8.05%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 41.44x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
21 /100
Unstable EPS volatility 567.68%
Profitable years 0
Beta 0.42x
Întreabă StockBot despre LBRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Heather D. Turner
Employees
27
Headquarters
New York
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report